Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers

Masamichi Ishioka, Norio Yasui-Furukori, Norio Sugawara, Hanako Furukori, Shuhei Kudo, Kazuhiko Nakamura Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Hirosaki, Japan Objective: The strong association between psychiatric patients who receive antipsychotics and t...

Full description

Bibliographic Details
Main Authors: Ishioka M, Yasui-Furukori N, Sugawara N, Furukori H, Kudo S, Nakamura K
Format: Article
Language:English
Published: Dove Medical Press 2015-02-01
Series:Neuropsychiatric Disease and Treatment
Online Access:http://www.dovepress.com/hyperprolactinemia-during-antipsychotics-treatment-increases-the-level-peer-reviewed-article-NDT

Internet

http://www.dovepress.com/hyperprolactinemia-during-antipsychotics-treatment-increases-the-level-peer-reviewed-article-NDT

Similar Items